TP53TG1 and hepatocellular carcinoma: In addition, the TP53TG1 knockout HCC cell line, sorafenib-resistance HCC cell line, and normal hepatocyte cell line can be considered in future studies to further determine the therapeutic effect and mechanism of TP53TG1 in HCC.